The global Fecal Transplant Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Fecal Transfusion Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Fecal Transplant Treatment include Enterome Bioscience, Rebiotix, Ritter Pharmaceuticals, Finch Therapeutics, Crestovo, MaaT Pharma, Seres Therapeutics, Second Genome and OpenBiome, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Fecal Transplant Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fecal Transplant Treatment. This report contains market size and forecasts of Fecal Transplant Treatment in global, including the following market information:
Global Fecal Transplant Treatment Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Fecal Transplant Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Fecal Transplant Treatment Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Fecal Transplant Treatment Market Segment Percentages, by Type, 2022 (%)
Fecal Transfusion
Fecal Bacteria Therapy
Fecal Enema
Fecal Transplant
Others
Global Fecal Transplant Treatment Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Fecal Transplant Treatment Market Segment Percentages, by Application, 2022 (%)
Parkinson's Diseaseo
Obesity
Autism
Clostridium Difficile Infection
Diabetes Mellitus
Others
Global Fecal Transplant Treatment Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Fecal Transplant Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Fecal Transplant Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Fecal Transplant Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Enterome Bioscience
Rebiotix
Ritter Pharmaceuticals
Finch Therapeutics
Crestovo
MaaT Pharma
Seres Therapeutics
Second Genome
OpenBiome
MicroBiome Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Fecal Transplant Treatment, market overview.
Chapter 2: Global Fecal Transplant Treatment market size in revenue.
Chapter 3: Detailed analysis of Fecal Transplant Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Fecal Transplant Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Fecal Transplant Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Fecal Transplant Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Fecal Transplant Treatment Overall Market Size
2.1 Global Fecal Transplant Treatment Market Size: 2022 VS 2029
2.2 Global Fecal Transplant Treatment Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Fecal Transplant Treatment Players in Global Market
3.2 Top Global Fecal Transplant Treatment Companies Ranked by Revenue
3.3 Global Fecal Transplant Treatment Revenue by Companies
3.4 Top 3 and Top 5 Fecal Transplant Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Fecal Transplant Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Fecal Transplant Treatment Players in Global Market
3.6.1 List of Global Tier 1 Fecal Transplant Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Fecal Transplant Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Fecal Transplant Treatment Market Size Markets, 2022 & 2029
4.1.2 Fecal Transfusion
4.1.3 Fecal Bacteria Therapy
4.1.4 Fecal Enema
4.1.5 Fecal Transplant
4.1.6 Others
4.2 By Type - Global Fecal Transplant Treatment Revenue & Forecasts
4.2.1 By Type - Global Fecal Transplant Treatment Revenue, 2018-2023
4.2.2 By Type - Global Fecal Transplant Treatment Revenue, 2024-2029
4.2.3 By Type - Global Fecal Transplant Treatment Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Fecal Transplant Treatment Market Size, 2022 & 2029
5.1.2 Parkinson's Diseaseo
5.1.3 Obesity
5.1.4 Autism
5.1.5 Clostridium Difficile Infection
5.1.6 Diabetes Mellitus
5.1.7 Others
5.2 By Application - Global Fecal Transplant Treatment Revenue & Forecasts
5.2.1 By Application - Global Fecal Transplant Treatment Revenue, 2018-2023
5.2.2 By Application - Global Fecal Transplant Treatment Revenue, 2024-2029
5.2.3 By Application - Global Fecal Transplant Treatment Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Fecal Transplant Treatment Market Size, 2022 & 2029
6.2 By Region - Global Fecal Transplant Treatment Revenue & Forecasts
6.2.1 By Region - Global Fecal Transplant Treatment Revenue, 2018-2023
6.2.2 By Region - Global Fecal Transplant Treatment Revenue, 2024-2029
6.2.3 By Region - Global Fecal Transplant Treatment Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Fecal Transplant Treatment Revenue, 2018-2029
6.3.2 US Fecal Transplant Treatment Market Size, 2018-2029
6.3.3 Canada Fecal Transplant Treatment Market Size, 2018-2029
6.3.4 Mexico Fecal Transplant Treatment Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Fecal Transplant Treatment Revenue, 2018-2029
6.4.2 Germany Fecal Transplant Treatment Market Size, 2018-2029
6.4.3 France Fecal Transplant Treatment Market Size, 2018-2029
6.4.4 U.K. Fecal Transplant Treatment Market Size, 2018-2029
6.4.5 Italy Fecal Transplant Treatment Market Size, 2018-2029
6.4.6 Russia Fecal Transplant Treatment Market Size, 2018-2029
6.4.7 Nordic Countries Fecal Transplant Treatment Market Size, 2018-2029
6.4.8 Benelux Fecal Transplant Treatment Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Fecal Transplant Treatment Revenue, 2018-2029
6.5.2 China Fecal Transplant Treatment Market Size, 2018-2029
6.5.3 Japan Fecal Transplant Treatment Market Size, 2018-2029
6.5.4 South Korea Fecal Transplant Treatment Market Size, 2018-2029
6.5.5 Southeast Asia Fecal Transplant Treatment Market Size, 2018-2029
6.5.6 India Fecal Transplant Treatment Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Fecal Transplant Treatment Revenue, 2018-2029
6.6.2 Brazil Fecal Transplant Treatment Market Size, 2018-2029
6.6.3 Argentina Fecal Transplant Treatment Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Fecal Transplant Treatment Revenue, 2018-2029
6.7.2 Turkey Fecal Transplant Treatment Market Size, 2018-2029
6.7.3 Israel Fecal Transplant Treatment Market Size, 2018-2029
6.7.4 Saudi Arabia Fecal Transplant Treatment Market Size, 2018-2029
6.7.5 UAE Fecal Transplant Treatment Market Size, 2018-2029
7 Fecal Transplant Treatment Companies Profiles
7.1 Enterome Bioscience
7.1.1 Enterome Bioscience Company Summary
7.1.2 Enterome Bioscience Business Overview
7.1.3 Enterome Bioscience Fecal Transplant Treatment Major Product Offerings
7.1.4 Enterome Bioscience Fecal Transplant Treatment Revenue in Global Market (2018-2023)
7.1.5 Enterome Bioscience Key News & Latest Developments
7.2 Rebiotix
7.2.1 Rebiotix Company Summary
7.2.2 Rebiotix Business Overview
7.2.3 Rebiotix Fecal Transplant Treatment Major Product Offerings
7.2.4 Rebiotix Fecal Transplant Treatment Revenue in Global Market (2018-2023)
7.2.5 Rebiotix Key News & Latest Developments
7.3 Ritter Pharmaceuticals
7.3.1 Ritter Pharmaceuticals Company Summary
7.3.2 Ritter Pharmaceuticals Business Overview
7.3.3 Ritter Pharmaceuticals Fecal Transplant Treatment Major Product Offerings
7.3.4 Ritter Pharmaceuticals Fecal Transplant Treatment Revenue in Global Market (2018-2023)
7.3.5 Ritter Pharmaceuticals Key News & Latest Developments
7.4 Finch Therapeutics
7.4.1 Finch Therapeutics Company Summary
7.4.2 Finch Therapeutics Business Overview
7.4.3 Finch Therapeutics Fecal Transplant Treatment Major Product Offerings
7.4.4 Finch Therapeutics Fecal Transplant Treatment Revenue in Global Market (2018-2023)
7.4.5 Finch Therapeutics Key News & Latest Developments
7.5 Crestovo
7.5.1 Crestovo Company Summary
7.5.2 Crestovo Business Overview
7.5.3 Crestovo Fecal Transplant Treatment Major Product Offerings
7.5.4 Crestovo Fecal Transplant Treatment Revenue in Global Market (2018-2023)
7.5.5 Crestovo Key News & Latest Developments
7.6 MaaT Pharma
7.6.1 MaaT Pharma Company Summary
7.6.2 MaaT Pharma Business Overview
7.6.3 MaaT Pharma Fecal Transplant Treatment Major Product Offerings
7.6.4 MaaT Pharma Fecal Transplant Treatment Revenue in Global Market (2018-2023)
7.6.5 MaaT Pharma Key News & Latest Developments
7.7 Seres Therapeutics
7.7.1 Seres Therapeutics Company Summary
7.7.2 Seres Therapeutics Business Overview
7.7.3 Seres Therapeutics Fecal Transplant Treatment Major Product Offerings
7.7.4 Seres Therapeutics Fecal Transplant Treatment Revenue in Global Market (2018-2023)
7.7.5 Seres Therapeutics Key News & Latest Developments
7.8 Second Genome
7.8.1 Second Genome Company Summary
7.8.2 Second Genome Business Overview
7.8.3 Second Genome Fecal Transplant Treatment Major Product Offerings
7.8.4 Second Genome Fecal Transplant Treatment Revenue in Global Market (2018-2023)
7.8.5 Second Genome Key News & Latest Developments
7.9 OpenBiome
7.9.1 OpenBiome Company Summary
7.9.2 OpenBiome Business Overview
7.9.3 OpenBiome Fecal Transplant Treatment Major Product Offerings
7.9.4 OpenBiome Fecal Transplant Treatment Revenue in Global Market (2018-2023)
7.9.5 OpenBiome Key News & Latest Developments
7.10 MicroBiome Therapeutics
7.10.1 MicroBiome Therapeutics Company Summary
7.10.2 MicroBiome Therapeutics Business Overview
7.10.3 MicroBiome Therapeutics Fecal Transplant Treatment Major Product Offerings
7.10.4 MicroBiome Therapeutics Fecal Transplant Treatment Revenue in Global Market (2018-2023)
7.10.5 MicroBiome Therapeutics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
112
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
116
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
115
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
112
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
115
|
View Report